IN BRIEF: Hikma Pharmaceuticals completes Custopharm deal
Hikma Pharmaceuticals PLC - London-based generic drugmaker - Completes acquisition of Custopharm Inc from Water Street Healthcare Partners, following approval from the US Federal Trade...
Thu, 21/04/2022 - 14:37